Header for print stylesheet
Go

What steps must be taken?

1. Pre-registration

The first step of the REACH process is pre-registration. Pre-registration will take place within a time frame of 6 months which will start on June 1, 2008 and will end on December 1, 2008.

2. Substance Information Exchange Forums (SIEF)

All manufacturers and importers that pre-register the same substance will automatically participate in
the SIEF for that substance. One substance, one SIEF. A SIEF facilitates the exchange of information and agreement on the classification and labeling of chemical substances. All participants provide the SIEF with existing studies, react to requests by others, identify possible needs for further studies and arrange to carry them out.

If studies are available among participants, then they must agree on shared costs. If the required studies are not available, the participants are to agree on who will perform a required study and how the costs will be distributed.

3. Registration

For the registration of a substance a volume-dependent set of data must be provided in a dossier. Substances in higher volumes or with hazard potential will have to meet additional information requirements. Manufacturers of the same substance may form a formal consortium in order to work together to create and submit a single dossier for that substance.

For substances above 10 ton per annum a chemical safety report (CSR) is required, including a basic risk assessment which describes how a substance should be handled for each intended use. This information will be transmitted downstream, through the extended safety data sheet.

The IT format for the registration of these dossiers is IUCLID5, an international standard for the reporting of (hazardous) substances information.

4. Authorization

During the registration process, substance dossiers will be assessed for completion, and some will receive additional attention with regard to the information provided on hazards and risks. ECHA will provide a list of candidate substances that they believe, on the basis of hazard potential, require further authorization.

Further test work or risk evaluation may be required to satisfy ECHA and Member States that these substances do not pose a risk to public or environmental health. In some cases market bans may result, for example where the hazard is deemed high and there is a technically feasible substitute.

Authorization involves the submission of a socioeconomic survey about the uses of the substance, an overview of alternatives for each use and an explanation as to why a specific substance can and should remain on the market for its intended use. The list of candidate substances for authorization will be compiled in 2009.

REACH

What is Reach?
Which substances?
More information
Q&A
Milestones

[an error occurred while processing this directive]
footer for print stylesheet